GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsHighNegative
Announced Fri, 3 Apr · 19:14 IST

Gufic Biosciences Limited has informed the Exchange about Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Regulatory & Legal View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹290.00
prior close
₹290.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.0-0.1-0.6-0.6+0.3+2.8+2.8+3.8+5.0+4.4-0.7+1.2+30.0+29.6
Up moveDown movePending
AI summary

Gufic Biosciences received an income tax assessment order for Assessment Year 2023-24. The original tax demand was Rs. 11.89 crore, which was substantially reduced to Rs. 11.76 lakh after the company's appeal. However, a penalty of Rs. 23.52 lakh has been levied under Section 270A(9) of the Income Tax Act for under-reported income. The order was received on April 3, 2026. The company intends to file a further appeal with the Commissioner of Income Tax (Appeals) and is hopeful of a favourable outcome based on advice from its tax consultants.

Likely market impact

The penalty amount of Rs. 23.52 lakh is relatively small compared to the company's financials, and the substantially reduced tax demand suggests a favourable appeal outcome. However, the company is contesting the penalty, creating uncertainty. Shareholders should monitor the outcome of the planned appeal.